Find your next paid study

M.D. Anderson Cancer CenterNCT06367972

Actual pay is set by the research site.

Phase 1

IT2023-08-ATKINS-ATHERO-RT: Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography

The prospective single-arm pilot study, ATHERO-RT: Real-Time Atherosclerosis Activity after Thoracic Radiotherapy using Sodium Fluoride Positron Emission Tomog…

Oligometastatic Disease

Katelyn AtkinsNCT06373497

~$150 – $4,500

Actual pay is set by the research site.

Phase 1

Pilot/Phase I Trial of Oligometastasis SBRT With Immediate, Simulation-Free Treatment Delivery (OLIGO-SWIFT)

This study is for participants whose cancer is oligometastatic, meaning it has spread to up to five spots in their body and their doctor recommends that they h…

OligometastasisOligometastatic Disease

Case Comprehensive Cancer CenterNCT07079098

~$150 – $3,000

Actual pay is set by the research site.

Prostate Cancer SurgeryProstate Cancer Metastatic Disease

Safety and Efficacy of OTL78 (Zopocianine), a Prostate-Specific Membrane Antigen (PSMA)-Targeted Fluorescent Agent, for Intraoperative Imaging of Prostate Cancer: A Phase IIb Trial

This study is being done to support the selection of single dose and timing regimen of Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent …

Clinton BahlerNCT07725523

~$75 – $3,000

Actual pay is set by the research site.

Observational

Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing to Improve Outcomes for Patients With Limited Metastatic Disease That Failed First-Line Systemic Therapy

This is a feasibility trial to assess use of OncoTarget and OncoTreat testing in a basket design of patients with oligmetastasis across various solid tumor his…

Personalized MedicineOligometastatic DiseaseFeasibility

Good Samaritan Hospital Medical Center, New YorkNCT06842030

Actual pay is set by the research site.

Observational

Contribution of Race to Nutritional Approach to Lower Cardiovascular Risk Factors in Men Undergoing Androgen Deprivation Therapy

There is a well-documented association between androgen deprivation therapy (ADT) and cardiovascular morbidity. A majority of men on ADT gain weight contributi…

Prostate Cancer Metastatic Disease

University of California, Los AngelesNCT06682390

Actual pay is set by the research site.

Prostate CancerOligometastatic Disease

Phase 2 Randomized Total Eradication of Metastatic Lesions Following Definitive Radiation to the Prostate in de Novo oligometaStatic Prostate Cancer (TERPS) Trial

This research is being done to see if we can improve the outcome of prostate cancer patients who present with metastatic lesions at initial diagnosis.

University of Maryland, BaltimoreNCT05223803

Actual pay is set by the research site.

Metastatic Renal Cell Carcinoma ( mRCC)OligoProgressive Metastatic Disease

STING Agonist and Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer.

To evaluate the impact of combining innate immune system activation (with IMSA101) with antigen release (through SAbR/PULSAR) on limited progressing lesions du…

University of Texas Southwestern Medical CenterNCT06601296

Actual pay is set by the research site.

Observational

Prospective Evaluation of PSMA PET Imaging in Surveillance Post-Focal Therapy for Prostate Cancer (PSMA-FT Surveillance Study)

This study is about adding PSMA PET (Prostate Specific Membrane Antigen- Positron Emission Tomography) to routine magnetic resonance imaging (MRI) scans to hel…

Prostate Cancer (Adenocarcinoma)Prostate Cancer (Diagnosis)Prostate Cancer Metastatic Disease

University of ChicagoNCT07115914

Actual pay is set by the research site.

Prostate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Disease+16 more

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (Fezo-ADT Trial)

The goal of this clinical trial is to learn if fezolinetant can treat hot flashes (vasomotor symptoms) in men with prostate cancer undergoing androgen deprivat…

Advanced CancerMetastatic DiseaseCancer Treatment+2 more

~$75 – $3,000

Actual pay is set by the research site.

Defining Symptom Trajectories to Inform Risk-Stratified Approaches to Symptom Management in Children With Advanced Cancer

The goal of this observational study is to understand how cancer makes children feel over time. The main things the researchers hope to learn are: * When and …

University of Wisconsin, MadisonNCT07804875

Actual pay is set by the research site.

Prostate Cancer Metastatic DiseaseProstate Cancers

Novel FAP-targeted Approach to Imaging Patients With or High-risk for Metastatic Prostate Cancer

The goal of this clinical trial is to gain more information about how FAPI (fibroblast activation protein inhibitor) binds to certain type of cells in the tumo…